DK1141250T3 - Intein-formidler cyklisering af peptider - Google Patents

Intein-formidler cyklisering af peptider

Info

Publication number
DK1141250T3
DK1141250T3 DK99966402T DK99966402T DK1141250T3 DK 1141250 T3 DK1141250 T3 DK 1141250T3 DK 99966402 T DK99966402 T DK 99966402T DK 99966402 T DK99966402 T DK 99966402T DK 1141250 T3 DK1141250 T3 DK 1141250T3
Authority
DK
Denmark
Prior art keywords
intein
peptides
methods
target peptide
cyclic
Prior art date
Application number
DK99966402T
Other languages
Danish (da)
English (en)
Inventor
Stephen J Benkovic
Charles P Scott
Ernesto V Abel-Santos
Original Assignee
Penn State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Penn State Res Found filed Critical Penn State Res Found
Application granted granted Critical
Publication of DK1141250T3 publication Critical patent/DK1141250T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DK99966402T 1998-12-18 1999-12-18 Intein-formidler cyklisering af peptider DK1141250T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11272398P 1998-12-18 1998-12-18
US15807799P 1999-10-07 1999-10-07

Publications (1)

Publication Number Publication Date
DK1141250T3 true DK1141250T3 (da) 2006-07-10

Family

ID=26810271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99966402T DK1141250T3 (da) 1998-12-18 1999-12-18 Intein-formidler cyklisering af peptider

Country Status (11)

Country Link
US (2) US7354756B1 (fr)
EP (1) EP1141250B1 (fr)
JP (1) JP4544601B2 (fr)
CN (1) CN1179040C (fr)
AT (1) ATE318894T1 (fr)
AU (1) AU781215B2 (fr)
CA (1) CA2355934A1 (fr)
DE (1) DE69930164T2 (fr)
DK (1) DK1141250T3 (fr)
ES (1) ES2260956T3 (fr)
WO (1) WO2000036093A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6781700A (en) * 1999-08-17 2001-03-13 Health Research Institute Genetic system and self-cleaving inteins derived therefrom, bioseparations and protein purification employing same, and methods for determining critical, generalizable amino acid residues for varying intein activity
US7378248B2 (en) 2000-03-06 2008-05-27 Rigel Pharmaceuticals, Inc. In vivo production of cyclic peptides for inhibiting protein-protein interaction
US7252952B2 (en) * 2000-03-06 2007-08-07 Rigel Pharmaceuticals, Inc. In vivo production of cyclic peptides for inhibiting protein—protein interaction
US7566765B2 (en) 2000-03-06 2009-07-28 Rigel Pharmaceuticals, Inc. Heterocyclic compounds containing a nine-membered carbon-nitrogen ring
EP1263777A2 (fr) 2000-03-06 2002-12-11 Rigel Pharmaceuticals, Inc. Production in vivo de peptides cycliques
EP1229330B1 (fr) * 2000-07-26 2007-02-21 Japan Science and Technology Agency Sonde permettant d'analyser une interaction protéine/protéine et méthode d'analyse utilisant cette sonde
US7279304B2 (en) 2000-12-18 2007-10-09 President And Fellows Of Harvard College Methods for preparation of macrocyclic molecules and macrocyclic molecules prepared thereby
WO2002074930A2 (fr) * 2001-03-20 2002-09-26 The Pennsylvania State Research Foundation Inteines trans pour rearrangement de domaine proteique et biopolymerisation
EP1468090B1 (fr) 2002-01-08 2014-10-29 Agrivida, Inc. Plantes transgeniques exprimant civps ou des proteines a inteine modifiee et procede associe
US7250551B2 (en) 2002-07-24 2007-07-31 President And Fellows Of Harvard College Transgenic mice expressing inducible human p25
JP4287633B2 (ja) * 2002-09-18 2009-07-01 独立行政法人科学技術振興機構 オルガネラ局在タンパク質の解析方法と解析材料
FI20021726A0 (fi) * 2002-09-27 2002-09-27 Ctt Cancer Targeting Tech Oy Menetelmä peptidien tuottamiseksi
US20040198958A1 (en) * 2002-12-11 2004-10-07 Ming-Qun Xu Carrier-ligand fusions and uses thereof
WO2005115433A2 (fr) * 2004-05-24 2005-12-08 Rigel Pharmaceuticals, Inc. Procedes de cyclisation de polymeres synthetiques
WO2008076938A1 (fr) * 2006-12-14 2008-06-26 University Of Iowa Research Foundation Méthode de fabrication de polypeptides cycliques à partir d'intéines
EP2106446A4 (fr) * 2007-01-10 2010-06-16 Univ Saskatchewan Stabilisation de structures de peptides cycliques
CN101638642B (zh) * 2008-08-01 2012-02-22 中国农业科学院生物技术研究所 提高了热稳定性及蛋白酶抗性的环化植酸酶
WO2010135277A2 (fr) 2009-05-18 2010-11-25 Brown University Analogues de glur6 cyclique, procédés de traitement et d'utilisation
US10407742B2 (en) 2009-11-06 2019-09-10 Agrivida, Inc. Intein-modified enzymes, their production and industrial applications
US8420387B2 (en) 2009-11-06 2013-04-16 Agrivida, Inc. Intein-modified enzymes, their production and industrial applications
US9464333B2 (en) 2009-11-06 2016-10-11 Agrivida, Inc. Intein-modified enzymes, their production and industrial applications
US9598700B2 (en) 2010-06-25 2017-03-21 Agrivida, Inc. Methods and compositions for processing biomass with elevated levels of starch
US10443068B2 (en) 2010-06-25 2019-10-15 Agrivida, Inc. Plants with engineered endogenous genes
WO2012019928A1 (fr) 2010-08-13 2012-02-16 Guntram Christiansen Présentation de peptide modifiée
EP2665744B1 (fr) * 2011-01-20 2015-04-08 University Of Rochester Composés macrocycliques ayant un squelette hybride peptidique/non-peptidique et procédés pour leur préparation
CN106244622B (zh) 2011-03-07 2020-06-12 谷万达公司 在工程植物中表达多种蛋白的表达盒和表达载体及制备工程植物和生产可溶性糖的方法
CA2850411C (fr) 2011-09-28 2023-08-15 Era Biotech, S.A. Inteines divisees et leurs utilisations
EP4219549A1 (fr) * 2012-06-27 2023-08-02 The Trustees of Princeton University Intéines fendues, conjugués et leurs utilisations
BR112015007466B1 (pt) 2012-10-03 2022-10-11 Agrivida, Inc Protease inteína-modificada, cassete de expressão, hospedeiro, método de produção de uma protease e detergente
DE102013016002A1 (de) 2013-09-26 2015-03-26 Forschungszentrum Jülich GmbH Zyklische, Amyloid-Beta-bindende Peptide und deren Verwendung
US10995118B2 (en) 2013-09-26 2021-05-04 Forschungszentrum Juelich Gmbh Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosis of alzheimer's disease
EP3087088B1 (fr) 2013-12-23 2022-05-25 University Of Rochester Procédés et compositions pour la synthèse ribosomique de peptides macrocycliques
JP6525171B2 (ja) 2015-04-13 2019-06-05 国立研究開発法人産業技術総合研究所 環状化サイトカイン及びその製法
CN106749497B (zh) * 2017-02-06 2020-10-30 陈铭 套索多肽的化学全合成
GB201702938D0 (en) * 2017-02-23 2017-04-12 Univ Southampton Methods of generating and screening compartmentalised peptides libraries
ES2895224T3 (es) * 2017-04-26 2022-02-18 Hunan Zonsen Peplib Biotech Co Ltd Procedimiento de construcción de biblioteca de péptidos
EP4218784A3 (fr) 2017-05-22 2023-09-13 National Hellenic Research Foundation Modulateurs macrocycliques de mauvais repliement et d'agrégation de protéines associés à une maladie
KR102000490B1 (ko) * 2018-01-12 2019-10-01 전남대학교산학협력단 가용성이 개선된 살모넬라균 편모 유래 플라젤린 단백질 발현 형질전환체, 그 제조방법 및 용도
GB201909491D0 (en) * 2019-07-01 2019-08-14 Governing Council Of The Univ Of Toronto Detection of protein to protein interactions
US20220372496A1 (en) * 2019-09-24 2022-11-24 MVRIX Co., Ltd. Nano-perforator having improved anti-viral activity
CN115093470B (zh) * 2022-06-30 2023-03-24 广州市乾相生物科技有限公司 内含肽Mtu RecA突变体及其在生产谷胱甘肽GSH中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643758A (en) * 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
DE69333667T2 (de) * 1992-12-09 2006-02-02 New England Biolabs, Inc., Beverly Kontrollierbare Zwischensequenzen enthaltende modifizierte Proteine und Verfahren zur deren Herstellung
US6194544B1 (en) 1993-07-09 2001-02-27 Smithkline Beecham Corporation Cyclic semi-random peptide libraries
US5498531A (en) * 1993-09-10 1996-03-12 President And Fellows Of Harvard College Intron-mediated recombinant techniques and reagents
EP1642980A1 (fr) 1995-06-28 2006-04-05 New England Biolabs, Inc. Protéines modifiées et procédé de leur obtention.

Also Published As

Publication number Publication date
AU781215B2 (en) 2005-05-12
DE69930164T2 (de) 2006-11-23
ATE318894T1 (de) 2006-03-15
US7354756B1 (en) 2008-04-08
US20070207502A1 (en) 2007-09-06
AU2194800A (en) 2000-07-03
EP1141250A2 (fr) 2001-10-10
CN1179040C (zh) 2004-12-08
JP2003534768A (ja) 2003-11-25
WO2000036093A2 (fr) 2000-06-22
WO2000036093A9 (fr) 2001-08-16
US7846710B2 (en) 2010-12-07
CN1354788A (zh) 2002-06-19
DE69930164D1 (de) 2006-04-27
CA2355934A1 (fr) 2000-06-22
WO2000036093A3 (fr) 2000-10-19
EP1141250B1 (fr) 2006-03-01
JP4544601B2 (ja) 2010-09-15
ES2260956T3 (es) 2006-11-01

Similar Documents

Publication Publication Date Title
DK1141250T3 (da) Intein-formidler cyklisering af peptider
CY1106620T1 (el) Μεθοδος για την παραγωγη τριπεπτιδιων
WO2004058946A3 (fr) Reseaux de proteines
ATE273320T1 (de) Fusogene liposomen
DK1149905T3 (da) Fremgangsmåder og præparat til polypeptidteknologi
WO2001034646A3 (fr) Gelatines de recombinaison
DK1870417T3 (da) Peptidacceptor-ligeringsmetoder
DE60041958D1 (de) Selektion von proteinen unter verwendung von rna-protein-fusionen
DE69934242D1 (de) Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen
WO2004041865A3 (fr) Anticorps a domaine unique stabilises
DE60127441D1 (de) Dipeptidylpeptidasen
ATE290014T1 (de) Festphasen-peptidsynthese
DK0911416T3 (da) Fremgangsmåde til fremstilling af protein
WO2003045975A3 (fr) Immobilisation en phase solide de proteines et de peptides
WO1996027665A3 (fr) Proteines ayant les proprietes d'un facteur silenceur exerçant une action de repression sur les neurones
DE60023860D1 (de) Verfahren zur herstellung von rekombinanten peptiden
DK1150999T3 (da) Cyclosporinderivater og fremgangsmåde til fremstilling deraf
PT1107981E (pt) Sintese de analogos peptidicos ciclicos de anel modificado
AU7216498A (en) Inhibitors of the urokinase receptor
WO2002034915A3 (fr) Segments preferes de la proteine neurale ntp et ses procedes d'utilisation
DE69811677T2 (de) Verfahren zur präparation von enantiomer-angereicherten, n-derivatisierten laktamen.
EA200200598A1 (ru) Генная терапия вич-инфицированных путем экспрессии заякоренных на мембране пептидов gp41
WO2002044195A3 (fr) Procede de sequençage de base et acides nucleiques bioactifs
WO2003004678A3 (fr) Nouveaux recepteurs
FR2752858B1 (fr) Armature, notamment destinee au support de faux-plafond